Back to Newsroom

International Stem Cell Names Ms. Ebrahimi as Chief Financial Officer

CARLSBAD, CA–(Marketwired – September 22, 2015) – International Stem Cell Corporation (OTCQB: ISCO) (, ISCO or the Company), a California-based biotechnology company developing novel stem cell-based therapies, today announced that it has named Mahnaz Ebrahimi as Chief Financial Officer, effective September 14, 2015. She replaced Jay Novak, whose employment with the company ended as of May 8, 2015.

Click here to read more